Cargando…

Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors

OBJECTIVE: To compare the number of oocytes obtained in the follicular puncture of high- responder oocyte donors, submitted to ovarian stimulation for in vitro fertilization (IVF) in two different protocols: Friendly and Conventional. METHODS: There were one hundred-and-eight infertile egg-donor wom...

Descripción completa

Detalles Bibliográficos
Autores principales: de Melo, Anderson Sanches, de Paula, Camilla Teles Vidal, dos Santos, Thiago Lopes, Faria, Victor Antonio Costa, Rufato, Marcelo Augusto Feres, Barboza, Rebecca Pontelo, Barreto, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Society of Assisted Reproduction 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118961/
https://www.ncbi.nlm.nih.gov/pubmed/34672261
http://dx.doi.org/10.5935/1518-0557.20210082
_version_ 1784710611081363456
author de Melo, Anderson Sanches
de Paula, Camilla Teles Vidal
dos Santos, Thiago Lopes
Faria, Victor Antonio Costa
Rufato, Marcelo Augusto Feres
Barboza, Rebecca Pontelo
Barreto, Jorge
author_facet de Melo, Anderson Sanches
de Paula, Camilla Teles Vidal
dos Santos, Thiago Lopes
Faria, Victor Antonio Costa
Rufato, Marcelo Augusto Feres
Barboza, Rebecca Pontelo
Barreto, Jorge
author_sort de Melo, Anderson Sanches
collection PubMed
description OBJECTIVE: To compare the number of oocytes obtained in the follicular puncture of high- responder oocyte donors, submitted to ovarian stimulation for in vitro fertilization (IVF) in two different protocols: Friendly and Conventional. METHODS: There were one hundred-and-eight infertile egg-donor women, aged between 21 and 35 years, undergoing IVF in this retrospective cohort study. The women were divided into two groups: 1) Friendly protocol: controlled ovarian stimulation (COS) with corifollitropin alpha, clomiphene citrate and dydrogesterone without daily rFSH (n=52) and 2) In the Conventional protocol, we had COS with menotropin daily and ganirelix (n=66). We assessed age, body mass index, time and cause of infertility, antral follicle count (AFC) by three-dimensional ultrasound, number of visits to the clinic, COS duration, number of follicles ≥14mm on the trigger day, early ovulation frequency, number of mature oocytes, number of cryopreserved embryos, clinical pregnancy rate, frequency of OHSS. RESULTS: The ovulatory factor was higher in women in the Conventional protocol (p=0.03), and the tubal factor (p=0.02) was higher in the Friendly protocol group. The number of visits to the clinic was lower among women in the Friendly protocol (p=0.04). The number of mature eggs, the clinical pregnancy rate and the frequency of OHSS were similar between the groups. The number of frozen embryos was higher in the Friendly group (p=0.02). The regression model demonstrated that the ovulatory factor, the tubal factor and the number of visits to the clinic were not predictors of the number of mature oocytes. Only AFC was an independent predictor of the number of meiosis II oocytes (p<0.01). CONCLUSIONS: The Friendly protocol seems to be as safe and effective as the Conventional protocol for infertile high-responder oocyte donors, resulting in a similar number of mature oocytes and OHSS incidence.
format Online
Article
Text
id pubmed-9118961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Brazilian Society of Assisted Reproduction
record_format MEDLINE/PubMed
spelling pubmed-91189612022-05-20 Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors de Melo, Anderson Sanches de Paula, Camilla Teles Vidal dos Santos, Thiago Lopes Faria, Victor Antonio Costa Rufato, Marcelo Augusto Feres Barboza, Rebecca Pontelo Barreto, Jorge JBRA Assist Reprod Original Article OBJECTIVE: To compare the number of oocytes obtained in the follicular puncture of high- responder oocyte donors, submitted to ovarian stimulation for in vitro fertilization (IVF) in two different protocols: Friendly and Conventional. METHODS: There were one hundred-and-eight infertile egg-donor women, aged between 21 and 35 years, undergoing IVF in this retrospective cohort study. The women were divided into two groups: 1) Friendly protocol: controlled ovarian stimulation (COS) with corifollitropin alpha, clomiphene citrate and dydrogesterone without daily rFSH (n=52) and 2) In the Conventional protocol, we had COS with menotropin daily and ganirelix (n=66). We assessed age, body mass index, time and cause of infertility, antral follicle count (AFC) by three-dimensional ultrasound, number of visits to the clinic, COS duration, number of follicles ≥14mm on the trigger day, early ovulation frequency, number of mature oocytes, number of cryopreserved embryos, clinical pregnancy rate, frequency of OHSS. RESULTS: The ovulatory factor was higher in women in the Conventional protocol (p=0.03), and the tubal factor (p=0.02) was higher in the Friendly protocol group. The number of visits to the clinic was lower among women in the Friendly protocol (p=0.04). The number of mature eggs, the clinical pregnancy rate and the frequency of OHSS were similar between the groups. The number of frozen embryos was higher in the Friendly group (p=0.02). The regression model demonstrated that the ovulatory factor, the tubal factor and the number of visits to the clinic were not predictors of the number of mature oocytes. Only AFC was an independent predictor of the number of meiosis II oocytes (p<0.01). CONCLUSIONS: The Friendly protocol seems to be as safe and effective as the Conventional protocol for infertile high-responder oocyte donors, resulting in a similar number of mature oocytes and OHSS incidence. Brazilian Society of Assisted Reproduction 2022 /pmc/articles/PMC9118961/ /pubmed/34672261 http://dx.doi.org/10.5935/1518-0557.20210082 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
de Melo, Anderson Sanches
de Paula, Camilla Teles Vidal
dos Santos, Thiago Lopes
Faria, Victor Antonio Costa
Rufato, Marcelo Augusto Feres
Barboza, Rebecca Pontelo
Barreto, Jorge
Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
title Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
title_full Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
title_fullStr Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
title_full_unstemmed Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
title_short Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
title_sort corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118961/
https://www.ncbi.nlm.nih.gov/pubmed/34672261
http://dx.doi.org/10.5935/1518-0557.20210082
work_keys_str_mv AT demeloandersonsanches corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors
AT depaulacamillatelesvidal corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors
AT dossantosthiagolopes corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors
AT fariavictorantoniocosta corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors
AT rufatomarceloaugustoferes corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors
AT barbozarebeccapontelo corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors
AT barretojorge corifollitropinalphaclomiphenecitrateanddydrogesteronewithoutdailygonadotrophinanewoptionofafriendlyprotocolforhighresponderoocytedonors